Key Points
- Liquidia director Stephen Bloch sold 85,062 shares on June 15 at an average price of $71.44, totaling about $6.1 million. After the sale, he still held 980,073 shares, a reduction of 7.99% in his position.
- Liquidia shares fell 5.3% in the session referenced, opening at $68.01. The stock has traded between a 12-month low of $11.85 and a high of $73.22.
- Recent earnings topped expectations, with Liquidia reporting $0.52 EPS versus the $0.41 consensus and revenue of $132.87 million, up sharply year over year. Analysts remain generally positive, with a consensus rating of “Moderate Buy” and an average price target of $60.29.
Liquidia Corporation (NASDAQ:LQDA - Get Free Report) Director Stephen Bloch sold 85,062 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $71.44, for a total value of $6,076,829.28. Following the completion of the transaction, the director directly owned 980,073 shares in the company, valued at approximately $70,016,415.12. This trade represents a 7.99% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Liquidia Stock Down 5.3%
Shares of Liquidia stock opened at $68.01 on Wednesday. The company has a quick ratio of 2.03, a current ratio of 2.22 and a debt-to-equity ratio of 1.18. Liquidia Corporation has a 12 month low of $11.85 and a 12 month high of $73.22. The business has a fifty day simple moving average of $51.14 and a 200 day simple moving average of $41.50. The stock has a market cap of $6.05 billion, a PE ratio of 485.82 and a beta of 0.58.
Liquidia (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings data on Monday, May 11th. The company reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.41 by $0.11. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The business had revenue of $132.87 million during the quarter, compared to analysts' expectations of $119.44 million. Liquidia's revenue for the quarter was up 4187.1% on a year-over-year basis. Research analysts predict that Liquidia Corporation will post 2.97 EPS for the current year.
Wall Street Analyst Weigh In
A number of equities research analysts recently commented on LQDA shares. Needham & Company LLC lifted their price objective on Liquidia from $54.00 to $70.00 and gave the stock a "buy" rating in a research note on Monday, May 11th. Jefferies Financial Group reaffirmed a "buy" rating and set a $60.00 price objective on shares of Liquidia in a research note on Monday, May 11th. Wall Street Zen raised Liquidia from a "buy" rating to a "strong-buy" rating in a research note on Saturday, May 16th. Zacks Research raised Liquidia from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, May 5th. Finally, Wells Fargo & Company lifted their price objective on Liquidia from $51.00 to $62.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 12th. Three equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Liquidia has an average rating of "Moderate Buy" and a consensus price target of $60.29.
Read Our Latest Stock Analysis on Liquidia
Institutional Trading of Liquidia
Several hedge funds have recently added to or reduced their stakes in the business. Covestor Ltd raised its stake in Liquidia by 41.9% during the 4th quarter. Covestor Ltd now owns 1,216 shares of the company's stock worth $42,000 after buying an additional 359 shares during the period. PNC Financial Services Group Inc. increased its holdings in Liquidia by 7.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company's stock worth $217,000 after purchasing an additional 422 shares in the last quarter. Quantinno Capital Management LP increased its holdings in Liquidia by 3.6% during the 1st quarter. Quantinno Capital Management LP now owns 17,165 shares of the company's stock worth $648,000 after purchasing an additional 589 shares in the last quarter. Northwestern Mutual Wealth Management Co. bought a new position in Liquidia during the 4th quarter worth about $25,000. Finally, ProShare Advisors LLC increased its holdings in Liquidia by 7.1% during the 4th quarter. ProShare Advisors LLC now owns 11,756 shares of the company's stock worth $405,000 after purchasing an additional 775 shares in the last quarter. Institutional investors and hedge funds own 64.54% of the company's stock.
Liquidia Company Profile
(
Get Free Report)
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
